3xERRE-luciferase Citations (4)

Originally described in: ERK/MAPK regulates ERRgamma expression, transcriptional activity, and receptor-mediated Tamoxifen resistance in ER+ breast cancer.
Heckler MM, Thakor H, Schafer CC, Riggins RB FEBS J. 2014 Mar 29. doi: 10.1111/febs.12797. PubMed Journal

---

Articles Citing 3xERRE-luciferase

Articles
Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRbeta2) splice variant in breast cancer. Heckler MM, Zeleke TZ, Divekar SD, Fernandez AI, Tiek DM, Woodrick J, Farzanegan A, Roy R, Uren A, Mueller SC, Riggins RB. Oncotarget. 2016 Jul 26;7(30):47201-47220. doi: 10.18632/oncotarget.9719. PubMed
The orphan nuclear receptor estrogen-related receptor beta (ERRbeta) in triple-negative breast cancer. Fernandez AI, Geng X, Chaldekas K, Harris B, Duttargi A, Berry VL, Berry DL, Mahajan A, Cavalli LR, Gyorffy B, Tan M, Riggins RB. Breast Cancer Res Treat. 2020 Feb;179(3):585-604. doi: 10.1007/s10549-019-05485-5. Epub 2019 Nov 19. PubMed
Nuclear Parkin Activates the ERRalpha Transcriptional Program and Drives Widespread Changes in Gene Expression Following Hypoxia. Shires SE, Quiles JM, Najor RH, Leon LJ, Cortez MQ, Lampert MA, Mark A, Gustafsson AB. Sci Rep. 2020 May 22;10(1):8499. doi: 10.1038/s41598-020-65438-7. PubMed
RB1 loss triggers dependence on ESRRG in retinoblastoma. Field MG, Kuznetsoff JN, Zhang MG, Dollar JJ, Durante MA, Sayegh Y, Decatur CL, Kurtenbach S, Pelaez D, Harbour JW. Sci Adv. 2022 Aug 19;8(33):eabm8466. doi: 10.1126/sciadv.abm8466. Epub 2022 Aug 19. PubMed

If you have published an article using this material, please email us at to have your article added to this page.